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Abstract 
Designing enzyme-like catalysts tests our understanding of sequence-to-
structure/function relationships in proteins. Here, we install hydrolytic activity 
predictably into a completely de novo and thermo-stable α-helical barrel, which 
comprises 7 helices arranged around an accessible channel. We show that the lumen 
of the barrel accepts 21 mutations to functional polar residues. The resulting variant, 
which has cysteine-histidine-glutamic acid triads on each helix, hydrolyses p-
nitrophenyl acetate with catalytic efficiencies matching the most-efficient redesigned 
hydrolases based on natural protein scaffolds. This is the first report of a functional 
catalytic triad engineered into a de novo protein framework. The flexibility of our 
system also allows the facile incorporation of unnatural side chains to improve 
activity and probe the catalytic mechanism. Such predictable and robust construction 
of truly de novo biocatalysts holds promise for applications in chemical and 
biochemical synthesis. 
 
(134 words) 
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Designing functional biomolecules de novo where both structure and function are built from 
first principles represents a considerable challenge. Enzyme-like catalysts constructed in this 
way would have wide-ranging uses for manipulating and synthesizing small molecules with 
potential applications in medicine, industrial biotechnology and basic science.1-3 Such 
endeavors test our ability to generate protein folds that are not, or are rarely, observed in 
nature,4 and also advance understanding of biological catalysis and how this might be 
emulated through design and engineering.  
Current approaches to enzyme design largely center on the redesign of existing, natural 
protein scaffolds selected from the Protein Data Bank (PDB).5,6 Arguably the most 
successful of these use theoretical enzyme substructures (“theozymes”) that can be 
incorporated into such proteins for experimental validation. The designs are selected through 
computational modeling of transition-state analogues within side-chain constellations.7,8 
Iterative rounds of computational design, both in the active site and surrounding residues, 
place mutations to stabilize the transition state with the aim of accelerating the target 
reaction. Successes of this approach include redesigned proteins with activities for the Kemp 
elimination,9 and the retro-aldol10 and Diels-Alder11 reactions. Often only moderate 
efficiencies are achieved, although these can be further improved by directed evolution.12-16 
Computational approaches have also been used to design esterases, again with moderate 
activities being achieved through the placement of a histidine (His) residue into the active 
site of thioredoxin,17 the C-terminal domain of calmodulin18 and cysteine-His (Cys-His) dyads 
installed into existing α/β protein folds.19  
By contrast, much less has been demonstrated for the design of completely de novo 
catalysts; that is, where both the protein scaffold and the catalytic activity are built from 
scratch.20-22 Although more challenging, this would carry advantages over redesign 
approaches: firstly, the designer could select and control all, or at least many of the residues, 
and so engineer the complete construct predictably; secondly, the resulting proteins could be 
made to function under conditions away from those required by natural proteins; and finally, 
success in this area would provide the acid test of our understanding of enzyme structure 
and function. Towards this fully de novo effort, successful designs of hydrolases have 
included: the decoration of small protein-folding motifs with His residues;23,24 the employment 
of Zn2+ cations as Lewis-acidic cofactors;25-28 and the identification of catalytically active 
proteins in combinatorial libraries of sequences patterned to form to all-α or all-β protein 
folds.29  
One of the most productive areas in the de novo design of protein structure has been for 
coiled-coil assemblies.30 Coiled coils are bundles of two or more α-helices, which wrap 
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around one another to form rope-like structures.31 Oligomer states above tetramer have 
central cavities of defined size and side-chain chemistry. As a result, they are best described 
as α-helical barrels.32,33 Recently, we have reported both the serendipitous discovery,34 and 
the rational, computational design of a series of α-helical barrels, including pentamers, 
hexamers and a heptamer.35 These structures have contiguous, mutable and accessible 
central channels,36 which provide a basis for the installation of functional residues with 
precision and within defined environments. Here, using the heptamer, CC-Hept, which is 
highly thermo-stable and has a channel 8 Å in diameter,35 we report that multiple mutations 
are accommodated in the lumen to give an α-helical barrel with catalytic activity.  
Results 
Rational design of multiple active sites  
We chose to mimic active sites found in the majority of natural cysteine/serine (Cys, C; Ser, 
S) hydrolases.37 In these, the Cys or Ser side chain acts as the nucleophile; the imidazole 
group of a proximal histidine (His, H) deprotonates the thiol or hydroxyl moiety; and an 
aspartic acid (Asp, D) or glutamic acid (Glu, E) residue polarizes the imidazole to activate 
the system further. 
As with most coiled coils, α-helical barrels are founded on sequence patterns of hydrophobic 
and polar residues in so-called heptad repeats, abcdefg.30,31 The a and d positions are 
hydrophobic leucine (Leu, L) and isoleucine (Ile, I) residues, respectively, and project into 
the central pore. We targeted these sites for mutation. The peptide sequence of CC-Hept 
has four heptad repeats, Table 1. Thus, there were 12 possible contiguous d-a-d or a-d-a 
sites where C-H-E or E-H-C triads could have been installed. Because of concerns over 
helix fraying, we discounted mutations near the termini and focused on those in the third 
heptad repeat. Using CCBuilder38 and structural parameters from the crystal structures of a 
range of de novo coiled coils,35,39 we generated in silico all-atom models for single, double 
and triple mutants as tetramers to heptamers (SI Table 1.1–1). Encouragingly, for 3 of the 5 
sequences heptamer was predicted as the most-stable state. With all 7 helices carrying the 
complete triad, a total of 21 mutations would be made to CC-Hept, corresponding to 10% of 
its residues. This places a high demand on the system. However, we posited that, in contrast 
to most natural protein structures, the high stability of de novo α-helical barrels and bundles 
might tolerate this level of change.35,40 To test this, we adopted an iterative design strategy, 
fully characterizing point and double mutants en route.  
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Table 1. Peptide sequences and heptad register for CC-Hept and the designed variants. 
Name Sequence and register      cdef gabcdef gabc def gabcdef gabcdef 
CC-Hept Ac-G EIAQ ALKEIAK ALKE IAW ALKEIAQ ALK     G-NH2 
CC-Hept-I-C-I Ac-G EIAQ ALKEIAK ALKE IAW ACKEIAQ ALK     G-NH2 
CC-Hept-I-H-I Ac-G EIAK ALREIAK ALRE IAW AHREIAK ALR     G-NH2 
CC-Hept-C-H-I Ac-G EIAK ALREIAK ALRE CAW AHREIAK ALR     G-NH2 
CC-Hept-H-C-I Ac-G EIAK ALREIAK ALRE HAW ACREIAK ALR     G-NH2 
CC-Hept-C-H-E Ac-G EIAK ALREIAK ALRE CAW AHREEAK ALR     G-NH2 
C-H-E-short Ac-G                RE CAW AHREEAK         G-NH2 
CC-Hept-C-H-E-outside Ac-G EIAK ALREIAC ALRH IAE ALREIAW ALR     G-NH2 
CC-Di-C-H-E Ac-G      EIAALKK EIAA LKC ENAHLKE EIAALKW G-NH2 
CC-Hept-C-L-E Ac-G EIAK ALREIAK ALRE CAW ALREEAK ALR     G-NH2 
CC-Hept-I-H-E Ac-G EIAK ALREIAK ALRE IAW AHREEAK ALR     G-NH2 
CC-Hept-hC-H-E* Ac-G EIAK ALREIAK ALREhCAW AHREEAK ALR     G-NH2 
CC-Hept-βMC-H-E* Ac-G EIAK ALREIAK ALREβCAW AHREEAK ALR     G-NH2 
* hC denotes homocysteine; βC denotes β-methyl cysteine. 
 
CC-Hept tolerates multiple, polar mutations in its lumen 
First, to test if CC-Hept could accommodate the key catalytic residues individually, singly 
mutated peptides incorporating Cys or His at the third a position were synthesized and 
characterized in solution. These were named systematically as CC-Hept-I-C-I and CC-Hept-
I-H-I (Table 1). Circular dichroism (CD) spectroscopy showed that both maintained high α-
helicity and thermal stability, with no loss of structure detected up to 90 °C (Fig. 1a&b). 
Sedimentation-velocity and sedimentation-equilibrium experiments conducted by analytical 
ultracentrifugation (AUC) returned molecular weights consistent with heptamers for both 
peptides (SI Fig 1.4–1&2). Finally, the design models were confirmed by determining X-ray 
crystal structures to atomic resolution. 1.95 and 1.80 Å resolution structures for CC-Hept-I-C-
I and CC-Hept-I-H-I, respectively, were obtained by molecular replacement using a poly-
alanine search model derived from the CC-Hept structure. The structure of CC-Hept-I-C-I 
revealed a corona of free-thiol Cys side chains with Sγ-Sγ distances of 4.2–4.7 Å, i.e. not-
disulfide linked helices; and that for CC-Hept-I-H-I showed a H-bonded ring of imidazole side 
chains (Fig. 2a&b).  
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Figure 1: Solution-phase biophysical characterisation of the designed peptides. a: CD 
spectra at 20 °C for CC-Hept-I-C-I (green), -I-H-I (blue), -C-H-I (red), -H-C-I (purple) and -C-H-E 
(orange). MRE, mean residue elipticity. The peptides are highly α-helical. b: Temperature-
dependence of the CD signal monitored at 222 nm. Same colour scheme as for panel a. The 
peptides are thermally stable. c: Sedimentation-velocity AUC c(s) distribution fit at 20 °C for CC-
Hept-C-H-E, which returned a molecular weight of 22,800 Da, equivalent to 6.8 × monomer mass. 
d: Sedimentation-equilibium AUC for CC-Hept-C-H-E, with experimental data (top, crosses), fits 
(lines) to single-ideal species and residuals (bottom) between the experimental and fitted data 
points. These data were recorded at 20 °C, 280 nm and at 16, 19 and 22 krpm.  The analysis 
returned a molecular weight of 24,060 Da (95% confidence limits 23,490–24,670 Da), equivalent to 
7.1 × monomer mass. au, arbitrary units. CC-Hept-C-H-E is heptameric in solution. Conditions: 
peptide concentrations of 10 µM (a and b), 150 µM (c), and 70 µM (d); phosphate-buffered saline 
(PBS, pH 7.4, a and b), HEPES-buffered saline (HBS, pH 7.0, c and d); 10-fold excess, relative to 
peptide, of tris-carboxyethylphosphine hydrochloride (TCEP) for Cys-containing sequences.   
 
Next, to establish the best spacing and order of these key residues, two double mutants 
were made, CC-Hept-C-H-I and CC-Hept-H-C-I (Table 1), with a Cys-His or His-Cys dyad at 
consecutive d and a sites. This is important as side chains at these positions project 
differently into the lumen of the barrel. Indeed, computational scoring with CCBuilder38 
predicted CC-Hept-C-H-I to be heptameric, but CC-Hept-H-C-I as a hexamer (SI Table 1.1–
1). Both synthetic peptides were highly α-helical and thermally stable (Fig. 1a). Moreover, 
the predicted oligomer states were verified by AUC experiments (SI Fig 1.4–3&4). Only an 
X-ray crystal structure of CC-Hept-C-H-I could be obtained. The 1.70 Å resolution structure 
confirmed a heptamer, and revealed the His side chain in an alternative rotamer to that 
observed in CC-Hept-I-H-I. This new conformer places the imidazole within 4 Å of the Cys 
thiol, with potential for a “catalytic” Cys-His interaction, although the geometry is not ideal as 
the thiol points away from the imidazole (Fig. 2c). Ordered water molecules were also 
observed H-bonded to each nitrogen atom of the His side chains. Thus, in this crystal 
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structure at least, the installed residues are accessible to water (Fig. 2d). For these reasons, 
we continued the design process with CC-Hept-C-H-I.  
 
Figure 2. X-ray crystal structures of CC-Hept mutants. a-c: Slices through the structures 
showing the installed residues in CC-Hept-I-C-I (a, PDB 5ez8, 1.95 Å), CC-Hept-I-H-I (b, 5ez9, 
1.80 Å) and CC-Hept-C-H-I (c, 5eza, 1.70 Å). Electron density (2Fobs-Fcalc) for the mutated side 
chains is shown contoured at 2 σ. d: Electron density, 2Fobs-Fcalc contoured at 1.5 σ, for the Cys-His 
dyad in CC-Hept-C-H-I, revealing water molecules hydrogen bonded to the His side chain 
(Nδ/Nε−OH2 = 2.9 Å). e:  CC-Hept-C-H-E (5ezc, 1.80 Å), which harbors 21 mutations within its 
lumen. f: Electron density, 2Fobs-Fcalc contoured at 1.2 σ, for the C-H-E triad of CC-Hept-C-H-E. All 
images created with PyMOL (https://www.pymol.org).  
 
Building further into the iterative design process, CC-Hept-C-H-E was modeled and 
synthesized. In this variant, Glu was placed at the d position immediately following the His of 
CC-Hept-C-H-I (Table 1). In total, this puts 21 polar mutations in the lumen of CC-Hept, 
which is otherwise lined by hydrophobic residues. Although approximately 25% less helical 
than the parent heptamer, CC-Hept-C-H-E was largely helical in solution, and had a 
cooperative and reversible unfolding transition with a TM of 57 °C (Fig. 1a&b). Importantly, 
AUC showed that the construct was heptameric in solution (Fig. 1c&d), which was 
confirmed by a 1.80 Å resolution X-ray crystal structure (Fig. 2e&f). In the latter, electron 
density was clearly visible for the Cys, His and Glu side chains and the pore size was 
maintained at ≈8 Å.41 The C-terminal regions of the helices had higher temperature factors 
(B-factors), suggesting fraying consistent with the decreased helicity in solution. The 
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structure showed the intended His-Glu H-bond (Oε-Nδ distance = 2.8 Å); and the Cys side 
chain adopted the same rotamer observed in CC-Hept-C-H-I. Whether the latter could adopt, 
or sample, different rotamers in solution was not clear from the X-ray crystal structure.19 That 
21 mutations, which corresponds to more than one third of the hydrophobic Ile or Leu 
residues, can be introduced into the lumen of CC-Hept is remarkable. These data highlight 
the hyperstability and mutability of these completely de novo α-helical barrels. 
Hydrolytic activity is observed with the dyad and triad variants 
For direct comparison to previous hydrolase designs,17-19 we used a colorimetric p-
nitrophenyl acetate (pNPA)-based assay to test for activity in the CC-Hept series. The 
single-mutant peptide assemblies, and hexameric CC-Hept-H-C-I showed no or little 
hydrolysis of pNPA above baseline at pH 7.0 (Fig. 3a). The heptameric CC-Hept-C-H-I did 
give product release over baseline, with an initial rate >10x background hydrolysis. However, 
considerably more activity was observed for CC-Hept-C-H-E, with initial rates >250x 
baseline (Fig. 3a). 
As a control, we made a short, unstructured peptide with Cys, His and Glu mutations at 
analogous sequence positions to CC-Hept-C-H-E (Table 1). This C-H-E-short peptide 
hydrolyzed pNPA at ≈1.5x the background rate (Fig. 3b). To probe the role of placing the 
triad within the lumen of the barrel over simply being in an α-helical configuration, an 
additional control peptide was made with the triad on the solvent-exposed exterior of a coiled 
coil. Initially, this was attempted with CC-Hept, but the peptide aggregated (Table 1; SI Fig 
1.3–7&8). Therefore, we used the homodimer, CC-Di,39 incorporating Cys, His and Glu at 
sequential f, c and f positions (Table 1). This peptide was highly α-helical, soluble and 
dimeric (SI Fig 1.3–9&10; SI Fig 1.4–5). In the hydrolysis assay, CC-Di-C-H-E was inactive 
like the C-H-E-short control (Fig. 3b). Thus, placing the side-chain constellation in the lumen 
of an α-helical barrel facilitates hydrolytic catalysis. 
Next, we knocked out these “active-site” residues. CC-Hept-C-H-I (vide supra) provided the 
Glu knockout, and the further Cys and His knockouts were synthesized. The His→Leu 
mutation, CC-Hept-C-L-E, eliminated all catalytic activity, and product generation returned to 
baseline levels (Fig 3b). Interestingly, the Cys→Ile mutation, CC-Hept-I-H-E, did generate 
product over the course of an hour (Fig. 3b), suggesting that the His residue can act as a 
nucleophile, though not as effectively as CC-Hept-C-H-E. Finally, to eliminate the possibility 
that divalent cations, such Zn2+, were participating in the mechanism of action of CC-Hept-C-
H-E, the assay was re-run in the presence of excess ethylenediaminetetraacetic acid 
(EDTA). The kinetic profile overlaid with the trace in the absence of EDTA (SI Fig 1.5–1). 
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Figure 3. Mechanistic and kinetic analysis of the reaction of the designed peptides with pNPA. 
a: Assay traces in the presence of CC-Hept-I-H-I (n), CC-Hept-I-C-I (r), CC-Hept-H-C-I (p), CC-
Hept-C-H-I (¢) and CC-Hept-C-H-E (l) against background hydrolysis (☐). Only CC-Hept-C-H-E 
shows appreciable catalysis and turnover of substrate. b: Assay traces for the control and “knock-out” 
peptides: C-H-E-short (u), CC-Di-C-H-E (!), CC-Hept-C-L-E (s), CC-Hept-C-H-I (¢) and CC-Hept-
I-H-E (q) against background hydrolysis (☐) with, for comparison, CC-Hept-C-H-E (l). c: Normalized 
HPLC traces for CC-Hept-C-H-E (dashed) and acylated CC-Hept-C-H-E after reaction with pNPA for 
10 min (*, solid line). d: MALDI-TOF MS of the new peak in c (labeled *) showing a singly acylated 
peptide intermediate. e: Proposed mechanism for the reaction of CC-Hept-C-H-E with pNPA via a 
thioester intermediate. f: Pre-steady state analysis of the first and second acylation events for the 
reaction of CC-Hept-C-H-E with pNPA; k2a/KS = 22.0 ± 2.0 M-1s-1. g: Michaelis-Menten plot for the 
turnover step; kcat/KM = 3.7 ± 0.6 M-1s-1. Conditions: 50 µM (a and b), 100 µM (c and d) and 10 µM (f 
and g) peptide concentrations, 10-fold excess of TCEP relative to peptide, 300 µM pNPA (a and b), 
HBS (pH 7.0, the optimum pH (SI Table 1.12–1)), 5% v/v CH3CN, 20 (a and b) and 22 ± 1 °C (f and 
g). Evolution of pNP was monitored at its pH-independent isosbestic point, 348 nm; ε = 5,400 cm-1M-1. 
For the fitted data in panels f and g [E]0 = 10 µM, the total concentration of peptide chains in the 
assay. Error bars represent standard deviations of at least three independent measurements. 
 
CC-Hept-C-H-E has enzyme-like behaviour 
The CC-Hept-C-H-E assembly had a distinct two-state kinetic profile (Fig. 3a), reminiscent of 
a “ping-pong” mechanism involving a covalently bound acyl intermediate as observed for the 
serine protease α-chymotrypsin with similar substrates.42 Furthermore, the y-intercept for the 
second, steady state curve of this profile matched the concentration of peptide in the assay. 
This indicates that the intermediate is present on each peptide chain of the heptamer. An 
acyl intermediate could be bound to the Cys (as a thioester) or the His (as an acyl-
imidazolium cation) side chains. We probed this by isolating a new species that appeared in 
HPLC of the reaction mixture (Fig. 3c). When analyzed by MALDI-TOF mass spectrometry 
(MS), the isolate gave a peak of the mass expected for CC-Hept-C-H-E plus 42 Da (Fig. 3d), 
consistent with single acylation of each of 7 peptide chains in the coiled-coil assembly. 
Moreover, MS/MS analysis of this peak confirmed acylation at the Cys residue only (Fig. 3e; 
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SI Fig 1.13–1).  Finally, CC-Hept-C-H-E effected robust catalysis with >9 turnovers in an 
extended 16-hour assay (SI Fig. 1.6–1). 
As a first step to determining complete kinetic parameters for the reaction of CC-Hept-C-H-E 
with pNPA, we fitted the kinetic profiles recorded for a range of substrate concentrations to a 
model with (1) an exponential pre-steady state parameter, followed by (2) a linear steady 
state parameter. This has been used for the reaction of α-chymotrypsin with pNP esters to 
deliver k2/Ks and kcat/KM, where KS is the pseudo KM for the acylation step.42 In our case, this 
model did not fit the experimental data (SI Fig. 1.11–1). However, fitting to a double 
exponential followed by a linear phase returned good fits, and was the simplest solution 
found (SI Fig. 1.11–1). This suggests that the acylation events of the burst phase do not 
occur at the same rate. This stands to reason given the demands on substrate entry, binding 
and product release in an 8 Å lumen with multiple active sites. The two pre-exponential 
terms indicate that the first and second acylation events occur faster than the remaining five 
(SI Table 1.11–1). The k2a/KS value for the first two acylation events was 22.0 ± 2.0 M-1s-1 
(Fig. 3f), which allows comparisons with foregoing hydrolase designs (vide infra). The 
overall catalytic efficiency of CC-Hept-C-H-E (kcat/KM) was 3.7 ± 0.6 M-1s-1 (Fig. 3g). 
Non-proteinogenic amino acids provide insight into the catalytic mechanism 
In an attempt to improve catalytic efficiency, we replaced Cys in CC-Hept-C-H-E with 
homocysteine (hCys), giving CC-Hept-hC-H-E (Table 1). The rationale was that the greater 
conformational flexibility of hCys should increase productive nucleophile-His encounters, and 
give better access of water to effect hydrolysis of the thioester intermediate. Balanced 
against this, however, the thiol of hCys is approximately 100-fold less acidic than that of Cys. 
CC-Hept-hC-H-E was folded, thermally stable (Fig. 4a; SI Fig. 1.3–15&16) and heptameric 
in solution (SI Fig. 1.4–8), which was confirmed by a 2.10 Å X-ray crystal structure. The 
latter revealed the hCys side chains as free thiols (Fig. 4e). CC-Hept-hC-H-E had catalytic 
activity with improved substrate turnover, carrying out three turnovers in 3 hours (Fig. 4b), 
and >12 in the extended 16-hour assay (SI Fig. 1.8–1). Conversely, the burst phase with 
CC-Hept-hC-H-E was slower than for CC-Hept-C-H-E, presumably because of the 
decreased nucleophilicity of the homocysteine side chain compared with cysteine.  
In the X-ray crystal structure of CC-Hept-C-H-E the Cys thiol group is further from the His 
side chain than is ideal for catalysis (Fig. 2f). Presumably, a more-active conformer of the 
Cys side chain can be accessed by rotation in solution.  We reasoned that modification of 
the Cys side chain to β-methyl-Cys should hold the thiol away from the His side chain 
permanently, and so reduce or even abolish activity. A β-methyl-Cys building block, Fmoc-L-
β-Me-Cys-(p-methoxybenzyl)-OH, suitable for peptide synthesis was made from L-Thr in 6 
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steps and a 13% overall yield (SI Scheme 1.15–1). A peptide incorporating this, CC-Hept-
βMC-H-E (Table 1), was folded and heptameric in solution (Fig. 4a; SI Fig. 1.4–9), and with 
pNPA was effectively inactive like the control peptide, C-H-E-short. This hinted that the 
nucleophile-His interaction had indeed been disrupted (Fig. 4b). A 1.80 Å resolution crystal 
structure for CC-Hept-βMC-H-E confirmed this, revealing the thiol groups of the βMC side 
chains forced away from the His side chains (Fig. 4f). This highlights the precision and 
predictability with which chemical groups can be installed into CC-Hept. 
 
Figure 4. Characterization and hydrolytic evaluation of CC-Hept-hC-H-E and CC-Hept-βMC-
H-E. a: CD spectra at 20 °C for CC-Hept-hC-H-E (black), CC-Hept-βMC-H-E (grey) and, for 
comparison, CC-Hept-C-H-E (orange). The mutated peptides are highly α-helical. b: Baseline-
corrected assay traces for the hydrolysis of 300 µM pNPA by CC-Hept-C-H-E (orange), CC-Hept-
hC-H-E (black) and CC-Hept-βMC-H-E (gray). CC-Hept-hC-H-E has improved turnover compared 
to CC-Hept-C-H-E. c: Pre-steady state analysis of the first and second acylation events for the 
reaction of CC-Hept-hC-H-E with pNPA at 22 ± 1 °C; k2a/KS = 11.9 ± 1.2 M-1s-1. d: Michaelis-
Menten plot for the turnover step; kcat/KM = 1.9 ± 0.2 M-1s-1. e: Electron density, 2Fobs-Fcalc 
contoured at 2 σ, for the hCys mutations in CC-Hept-hC-H-E (5f2y, 2.10 Å). f: Overlay of the seven 
chains of CC-Hept-βMC-H-E (5eze, 1.80 Å) displaying the βMC and His mutations, with the thiol 
forced from the His side chain. Conditions: 10 µM (a, c and d) and 50 µM (b) peptide 
concentrations; PBS (a), HBS (b, c and d); 10-fold excess of TCEP relative to peptide; 5% v/v 
CH3CN (b, c and d). For the fitted data in panels c and d, [E]0 = 10 µM, the concentration of 
peptide chains in the assay. Error bars represent standard deviations of at least three independent 
measurements. Images e and f were created in PyMOL (https://www.pymol.org). 
 
Discussion 
We have described the successful installation of multiple catalytic triads into a completely de 
novo protein framework. Hydrolytic activity is observed when Cys-His-Glu catalytic triads are 
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installed into the lumen of a de novo designed heptameric α-helical barrel, CC-Hept, with 
improved turnover achieved when hCys is used as the nucleophile. Forcing the thiol from the 
His side chain, by adding a β-methyl group, abolishes the pre-steady state kinetic profiles. 
The kinetic profile for ester hydrolysis by CC-Hept-C-H-E is clearly two-state (Fig. 3a). We 
interpret this as follows: the initial burst phase corresponds to the formation of a thioester 
intermediate with release of pNP (Fig. 3e; k2/KS); this is then followed by a rate-limiting 
slower phase, corresponding to the hydrolysis of this adduct and release of acetate (Fig. 3e; 
k3). This “ping-pong” mechanism is well established for α-chymotrypsin, which displays 
similar profiles with pNP esters and proceeds via an ester intermediate;42 and it is similar to 
that proposed for previously designed hydrolase catalysts.19 Rapid and stoichiometric 
acylation within the heptameric barrel leads to seven acylated Cys side chains, followed by 
rate-limiting hydrolysis of the thioester intermediate. In support of this mechanism, we could 
not find any evidence for acylation at His. That said, acylation was observed in assays with 
the Cys-knockout peptide CC-Hept-I-H-E (SI Fig. 1.10–1). This suggests that His may act as 
the nucleophile, but not in the presence of an adjacent superior nucleophile (Cys or hCys). 
Furthermore, a mechanism where N-acylation is followed by N→S acyl shift can be 
discounted as this would be expected to have a burst phase equivalent to double the 
concentration of peptide chains in the assay. 
Kinetic analysis of the burst phase of the reaction of CC-Hept-C-H-E with pNPA gives k2a/KS 
= 22.0 ± 2.0 M-1s-1 for the first two acylation events, which compares favorably with 
previously reported redesign studies using natural protein scaffolds (Table 2 entries 6–9), 
and is ≈30x more efficient than the de novo designed KO-42 peptide catalyst.23 The overall 
catalytic efficiency (kcat/KM = 3.7 ± 0.6 M-1s-1) is approximately equal to previous redesign 
attempts (Table 2 entries 3, 8&9). In our case, the reaction is turned over expelling acetate, 
and it is not driven by other nucleophilic side chains near the active site, which can become 
irreversibly acylated as the reaction proceeds contributing to observed kinetic profiles.18,29 
Indeed, even over a long time course and >6 turnovers, we observed only one small 
additional peak by MALDI-TOF MS at [M+84] Da (SI Fig. 1.7–1), indicating limited 
secondary acylation. For CC-Hept-hC-H-E, the burst phase is slowed and kcat improved 
compared with CC-Hept-C-H-E (Fig. 4c). This is consistent with the mechanism and 
designs: the lower nucleophilicity of homocysteine affecting the first step is compensated by 
the increased conformational flexibility of the acylated side chain, which improves turnover 
(Fig. 4d).  
Our best design is ≈10x less efficient than recently reported Zn2+-dependent hydrolase 
designs (Table 2 entries 10, 12&13), where the reaction proceeds via direct hydrolysis of the 
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substrate without a thioester intermediate, thus removing the requirement for His to activate 
water in the hydrolytic step; and it is still ≈103x less efficient than the reaction of the natural 
enzyme α-chymotrypsin with the unnatural substrate pNPA.43,44 We envisage improving the 
efficiency and selectivity of our designs in the future through directed evolution of residues 
close to the active site,12 and/or via the precise installation of a surrogate for the oxyanion 
hole to stabilize the tetrahedral intermediates.19 
In conclusion, this is the first report of catalytically active Cys-His-Glu triads being installed 
into a completely de novo protein framework. In total, seven such triads have been 
engineered into a heptameric α-helical barrel, resulting in hydrolytic activities comparable to 
those achieved in previous enzyme redesigns using natural scaffolds without metal 
cofactors. Moreover, the peptide-based architecture that we describe allows the facile 
introduction of standard and non-canonical amino acids predictably to test and control 
aspects of the mechanism of action of these de novo assemblies. Therefore, this study 
highlights the possibilities for using highly stable, mutable and completely de novo 
architectures as scaffolds for the precise and predictable introduction of catalytic function.  
Table 2. Kinetic parameters for the hydrolysis of pNPA by de novo and redesigned catalysts at 
25 °C. 
No. Catalyst 
k2 × 102 
(s-1) 
KS (µM) 
k2/KS 
(M-1s-1) 
kcat × 102 
(s-1) KM (µM) 
kcat/KM 
(M-1s-1) 
1 CC-Hept-C-H-Ea,d,i 0.83 ± 0.1 377 ± 67 22.0 ± 2.0 0.05 ± 0.0 134 ± 36 3.7 ± 0.6 
2 CC-Hept-hC-H-Ea,d,i 0.72 ± 0.1 604 ± 134 11.9 ± 1.2 0.07 ± 0.0 373 ± 60 1.9 ± 0.2 
3 PZD2d 17 - - - 0.05 ± 0.0 170 ± 20 2.70 
4 KO-42d 23 - - ≈ 0.7 - - - 
5 S824e 29 - - - 0.55 3000 1.83 
6 FR29b,f 19 0.41 ± 0.1 120 ± 20 34 - - - 
7 FR29 A44S/T112L/V151Lb,f 19 1.54 ± 1.1 38 ± 5 405 - - - 
8 AlleyCatEf 18 1.3 ± 0.2 400 ± 70 32.5 ± 2.8 0.4 ± 0.2 700 ± 300 5.5 ± 0.8 
9 AlleyCatE2f 18 1.5 ± 0.2 200 ± 24 76.7 ± 8.3 0.12 ± 0.0 200 ± 15 6 ± 0.5 
10 Ac-IHIHIQI-CONH2 c,g 25 - - - 2.6 ± 0.0 400 ± 100 62 ± 2 
11 (TRIL9CL23H)3+ c,f 26 - - - 0.02 ± 0.01 1600 ± 400 
1.38 ± 
0.04 
12 MID1-zincc 27 - - - 4.2 ± 0.1 1180 ± 100 35 
13 A104AB3c,h 28 - - - 2.7 ± 0.8 850 32 ± 8 
a 22 ± 1 °C. b 29 °C and with p-nitrophenyl-2-phenylpropanoate. c In the presence of Zn2+. d pH 7.0. e pH 7.3. f pH 
7.5. g pH 8.0. h pH 9.0. i k2a/KS for the first two acylation events.  For rows 1 and 2, errors were obtained from 
fitting of the Michaelis-Menten equation to the data in SigmaPlot 13.0, with at least three independent runs per 
data point; for the other rows see the original papers. 
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Methods 
Peptide synthesis and purification 
Peptides were synthesised by standard Fmoc solid-phase peptide synthesis (SPPS) methods on a 
CEM (Buckingham, UK) Liberty Blue automated synthesizer with inline UV monitoring on a 0.1 mmol 
scale. Peptide coupling was achieved using DIC/HOBt activation and standard coupling protocols on 
Rink amide ChemMatrix resin. All peptides were cleaved from the resin as C-terminal amides. 
Iterative Fmoc deprotections were carried out with 20% v/v piperidine or morpholine in DMF. All 
peptides were N-terminally acetylated on addition of acetic anhydride (0.25 ml) and pyridine (0.30 ml) 
in DMF (5 ml) for 20 min at RT. Cleavage from the solid support and side-chain deprotection (with the 
exception of CC-Hept-βMC-H-E; Supplementary methods) was effected by addition of 15 ml of a 
95:2.5:2.5 v/v TFA:H2O:TIPS solution followed by shaking for 3 h at rt. Following cleavage, the 
solution was reduced to ca. 5 ml in volume under a flow of nitrogen. The crude peptides were 
precipitated using cold diethyl ether (45 ml), recovered via refrigerated centrifugation at 4 krpm, re-
dissolved in 1:1 CH3CN:H2O (10 ml) and lyophilized to yield a white solid.   
Crude peptides were purified by reversed-phase HPLC running a gradient of 20 to 80% CH3CN in 
H2O over 30 min on a Phenomenex (Macclesfield, UK) Luna® 5 µm particle size, 100 Å pore size, C18 
stationary-phase column (150 × 10 mm), with UV detection at 220 and 280 nm. More-hydrophobic 
and shortened peptides were purified with gradients of 40 – 100% or 0 – 60% CH3CN in H2O over 30 
min, respectively, on the same column. All buffers contained 0.1% TFA. Pure fractions were identified 
by analytical HPLC and MALDI-TOF MS (Supplementary methods), and were pooled and 
lyophilized. 
UV/vis activity assays 
Activity assays were carried out in a 1 or 10 mm path length quartz cuvette on a Perkin-Elmer 
(Coventry, UK) Lambda 25 spectrophotometer, recording at 348 nm (the pH-independent isosbestic 
point for p-nitrophenol (pNP; ε = 5,400 cm-1M-1)) at 20 °C. Solutions were made up in HEPES-buffered 
saline (HBS) to a final peptide concentration of 50 µM with a 10-fold excess of TCEP for all peptides. 
A freshly prepared solution of pNPA in CH3CN was added (300 µM final concentration; the final 
CH3CN content was 5%) and measurements were taken in triplicate at 30 s intervals to a total time of 
1 or 3 h. Data were background corrected (measured in the presence of TCEP), and errors obtained 
from the standard deviation of the repeats. 
Kinetic assays 
Kinetic assays were carried out in a 10 mm path length quartz cuvette on an Agilent (Stockport, UK) 
Cary-100 UV/vis spectrophotometer recording at 348 nm at 22 ± 1 °C. Solutions were made up in 
HBS to a final peptide concentration of 10 µM with a 10-fold excess of TCEP. A freshly prepared 
solution of pNPA in CH3CN was added (100–1250 µM final concentration; the final CH3CN content 
was 5%) and measurements were taken in triplicate at 1 s intervals at a 0.1 s averaging time to a total 
time of 0.5, 1 or 16 h (for extended time course measurements). Data were background corrected 
(measured in the presence of TCEP), and errors obtained from the standard deviation of the repeats. 
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Fitting of the obtained curves was carried out following the method of Bender et al.42 Where k2, KS, kcat 
and KM can be obtained by fitting of pre-steady state kinetic curves to an equation with an exponential 
and a linear term. In the case of CC-Hept-C-H-E and CC-Hept-hC-H-E fitting to a double exponential 
and a linear term returned a good fit to the data (SI Fig. 1.11–1). The data were fitted to Equation 1 
in SigmaPlot 13.0, where the sum of the pre-exponentials a and c approximately equaled the 
concentration of peptide in the assay (10 µM; SI Table 1.11–1), b and d are the rate constants k2a and 
k2b, respectively, and g is k3. 𝑓 = 𝑎 1 − 𝑒 !!" +   𝑐 1 − 𝑒 !!" + 𝑔𝑥  Equation 1 
The kinetic parameters were determined via fitting of the obtained rate constants across the range of 
substrate concentrations to the Michaelis-Menten equation in SigmaPlot 13.0, with errors obtained 
from the fits. [E]0 = 10 µM, the concentration of peptide chains in the assay. 
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